Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Baricitinib helps treat severe hair loss in people over 65.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Baricitinib is not very effective for severe alopecia areata.

QLT0267 stops hair follicle cell growth and movement.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

JAK inhibitors offer new hope for treating severe alopecia areata.

JAK inhibitors are generally safe for alopecia areata and atopic dermatitis, with mostly mild side effects.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Stopping afatinib improved a rare scalp condition in a patient.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Baricitinib successfully treated severe hair loss.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Baricitinib is a promising treatment for alopecia areata.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.